Rosuvastatin counteracts vessel arterialisation and sinusoid capillarisation, reduces tumour growth, and prolongs survival in murine hepatocellular carcinoma

Gastroenterology Research and Practice

Volumn , Issue , 2010, Pages

  Tijeras Raballand, Annemilaï ^a,b,c   Hainaud Hakim, Patricia ^a,b,c   Contreres, Jean Olivier ^a,b,c   Gest, Caroline ^d   Le Henaff, Carole ^a,b,c   Levy, Bernard I ^a,b,c,e   Pocard, Marc ^b,c   Soria, Claudine ^b   Dupuy, Evelyne ^a,b,c  

^a Institut des Vaisseaux et du Sang   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ DE ROUEN   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ; NOTCH4 RECEPTOR; ROSUVASTATIN; SMOOTH MUSCLE ACTIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CELL FUNCTION; CONGENITAL BLOOD VESSEL MALFORMATION; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER CELL CARCINOMA; LIVER NODULE; LIVER SINUSOID; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STELLATE CELL; TRANSGENICS; TUMOR GROWTH;

EID: 79955080355     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2010/640797     Document Type: Article

References (42)

1. Fernndez M., Semela D., Bruix J., Colle I., Pinzani M., Bosch J., Angiogenesis in liver disease Journal of Hepatology 2009 50 3 604 620
2. Ribatti D., Vacca A., Nico B., Sansonno D., Dammacco F., Angiogenesis and anti-angiogenesis in hepatocellular carcinoma Cancer Treatment Reviews 2006 32 6 437 444 (Pubitemid 44309250)
3. Llovet J. M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J. F., De Oliveira A. C., Santoro A., Raoul J. L., Forner A., Schwartz M., Porta C., Zeuzem S., Bolondi L., Greten T. F., Galle P. R., Seitz J. F., Borbath I., Hussinger D., Giannaris T., Shan M., Moscovici M., Voliotis D., Bruix J., Sorafenib in advanced hepatocellular carcinoma New England Journal of Medicine 2008 359 4 378 390
4. Montero J., Morales A., Llacuna L., Lluis J. M., Terrones O., Basaez G., Antonsson B., Prieto J., Garca-Ruiz C., Colell A., Fernndez-Checa J. C., Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma Cancer Research 2008 68 13 5246 5256
5. Jakobisiak M., Golab J., Statins can modulate effectiveness of antitumor therapeutic modalities Medicinal Research Reviews 2010 30 1 102 135
6. Kuoppala J., Lamminp A., Pukkala E., Statins and cancer: a systematic review and meta-analysis European Journal of Cancer 2008 44 15 2122 2132
7. El-Serag H. B., Johnson M. L., Hachem C., Morgana R. O., Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes Gastroenterology 2009 136 5 1601 1608
8. Argo C. K., Loria P., Caldwell S. H., Lonardo A., Statins in liver disease: a molehill, an iceberg, or neither? Hepatology 2008 48 2 662 669
9. Kawata S., Yamasaki E., Nagase T., Inui Y., Ito N., Matsuda Y., Inada M., Tamura S., Noda S., Imai Y., Matsuzawa Y., Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial British Journal of Cancer 2001 84 7 886 891 (Pubitemid 32385829)
10. Graf H., Jngst C., Straub G., Dogan S., Hoffmann R. T., Jakobs T., Reiser M., Waggershauser T., Helmberger T., Walter A., Walli A., Seidel D., Gke B., Jngst D., Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma Digestion 2008 78 1 34 38
11. Dulak J., Jzkowicz A., Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy Current Cancer Drug Targets 2005 5 8 579 594 (Pubitemid 41789598)
12. Urbich C., Dernbach E., Zeiher A. M., Dimmeler S., Double-edged role of statins in angiogenesis signaling Circulation Research 2002 90 6 737 744 (Pubitemid 34640894)
13. Weis M., Heeschen C., Glassford A. J., Cooke J. P., Statins have biphasic effects on angiogenesis Circulation 2002 105 6 739 745 (Pubitemid 34157379)
14. Zhu X. Y., Daghini E., Chade A. R., Lavi R., Napoli C., Lerman A., Lerman L. O., Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation Life Sciences 2008 83 23-24 801 809
15. Demierre M. F., Higgins P. D. R., Gruber S. B., Hawk E., Lippman S. M., Statins and cancer prevention Nature Reviews Cancer 2005 5 12 930 942 (Pubitemid 41766782)
16. Graaf M. R., Richel D. J., van Noorden C. J. F., Guchelaar H. J., Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer Cancer Treatment Reviews 2004 30 7 609 641 (Pubitemid 39451828)
17. Vincent L., Soria C., Mirshahi F., Opolon P., Mishal Z., Vannier J. P., Soria J., Hong LI., Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 4 623 629 (Pubitemid 34408744)
18. Bergers G., Benjamin L. E., Tumorigenesis and the angiogenic switch Nature Reviews Cancer 2003 3 6 401 410 (Pubitemid 37328844)
19. Jain R. K., Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 2005 307 5706 58 62 (Pubitemid 40093472)
20. McDonald D. M., Baluk P., Imaging of angiogenesis in inflamed airways and tumors: newly formed blood vessels are not alike and may be wildly abnormal: Parker B. Francis lecture Chest 2005 128 6 602S 108S
21. Xu BO., Broome U., Uzunel M., Nava S., Ge X., Kumagai-Braesch M., Hultenby K., Christensson B., Ericzon B. G., Holgersson J., Sumitran-Holgersson S., Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis American Journal of Pathology 2003 163 4 1275 1289 (Pubitemid 37175077)
22. Dupuy E., Hainaud P., Villemain A., Bodevin-Phdre E., Brouland J. P., Briand P., Tobelem G., Tumoral angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model Journal of Hepatology 2003 38 6 793 802 (Pubitemid 36613346)
23. Hainaud P., Contrers J. O., Villemain A., Liu L. X., Plout J., Tobelem G., Dupuy E., The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-Ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions Cancer Research 2006 66 17 8501 8510 (Pubitemid 44449163)
24. Bonnin P., Villemain A., Vincent F., Debbabi H., Silvestre J. S., Contreres J. O., Levy B. I., Tobelem G., Dupuy E., Ultrasonic assessment of hepatic blood flow as a marker of mouse hepatocarcinoma Ultrasound in Medicine and Biology 2007 33 4 561 570 (Pubitemid 46476827)
25. Van de Veire S., Stalmans I., Heindryckx F., Oura H., Tijeras-Raballand A., Schmidt T., Loges S., Albrecht I., Jonckx B., Vinckier S., Van Steenkiste C., Tugues S., Rolny C., De Mol M., Dettori D., Hainaud P., Coenegrachts L., Contreres J. O., Van Bergen T., Cuervo H., Xiao W. H., Le Henaff C., Buysschaert I., Masouleh B. K., Geerts A., Schomber T., Bonnin P., Lambert V., Haustraete J., Zacchigna S., Rakic J. M., Jimnez W., Nol A., Giacca M., Colle I., Foidart J. M., Tobelem G., Morales-Ruiz M., Vilar J., Maxwell P., Vinores S. A., Carmeliet G., Dewerchin M., Claesson-Welsh L., Dupuy E., Van Vlierberghe H., Christofori G., Mazzone M., Detmar M., Collen D., Carmeliet P., Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease Cell 2010 141 1 178 190
26. Rossant J., Hirashima M., Vascular development and patterning: making the right choices Current Opinion in Genetics and Development 2003 13 4 408 412 (Pubitemid 36897805)
27. Kume T., Novel insights into the differential functions of Notch ligands in vascular formation Journal of Angiogenesis Research 2009 1 8
28. Riccalton-Banks L., Bhandari R., Fry J., Shakesheff K. M., A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue Molecular and Cellular Biochemistry 2003 248 1-2 97 102 (Pubitemid 36833646)
29. Fukui K., Tamura S., Wada A., Kamada Y., Sawai Y., Imanaka K., Kudara T., Shimomura I., Hayashi N., Expression and prognostic role of RhoA GTPases in hepatocellular carcinoma Journal of Cancer Research and Clinical Oncology 2006 132 10 627 633 (Pubitemid 44310328)
30. Sterpetti P., Marucci L., Candelaresi C., Toksoz D., Alpini G., Ugili L., Baroni G. S., Macarri G., Benedetti A., Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals American Journal of Physiology 2006 290 4 G624 G632
31. Taras D., Blanc J. F., Rullier A., Dugot-Senant N., Laurendeau I., Vidaud M., Rosenbaum J., Pravastatin reduces lung metastasis of rat hepatocellular carcinoma via a coordinated decrease of MMP expression and activity Journal of Hepatology 2007 46 1 69 76 (Pubitemid 44834427)
32. Kim W., Yoon J. H., Kim J. R., Jang IN. J., Bang Y. J., Kim Y. J., Lee H. S., Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma Cancer Chemotherapy and Pharmacology 2009 64 3 497 507
33. Gao J., Song Z., Chen Y., Xia L., Wang J., Fan R., Du R., Zhang F., Hong L., Song J., Zou X., Xu H., Zheng G., Liu J., Fan D., Deregulated expression of Notch receptors in human hepatocellular carcinoma Digestive and Liver Disease 2008 40 2 114 121
34. Qi R., An H., Yu Y., Zhang M., Liu S., Xu H., Guo Z., Cheng T., Cao X., Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis Cancer Research 2003 63 23 8323 8329 (Pubitemid 37549485)
35. Ning LI., Wentworth L., Chen H., Weber S. M., Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma American Journal of Translational Research 2009 1 4 358 366
36. Jakobsson L., Bentley K., Gerhardt H., VEGFRs and Notch: a dynamic collaboration in vascular patterning Biochemical Society Transactions 2009 37 6 1233 1236
37. Carlson T. R., Yan Y., Wu X., Lam M. T., Tang G. L., Beverly L. J., Messina L. M., Capobianco A. J., Werb Z., Wang R., Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice Proceedings of the National Academy of Sciences of the United States of America 2005 102 28 9884 9889 (Pubitemid 40993662)
38. Murphy P. A., Lam M. T. Y., Wu X., Kim T. N., Vartanian S. M., Bollen A. W., Carlson T. R., Wang R. A., Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice Proceedings of the National Academy of Sciences of the United States of America 2008 105 31 10901 10906
39. Miniati D., Jelin E. B., Ng J., Wu J., Carlson T. R., Wu X., Looney M. R., Wang R. A., Constitutively active endothelial Notch4 causes lung arteriovenous shunts in mice American Journal of Physiology 2010 298 2 L169 L177
40. Wu X. Z., Xie G. R., Chen D., Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma Journal of Gastroenterology and Hepatology 2007 22 8 1178 1182 (Pubitemid 47222667)
41. Taura K., De Minicis S., Seki E., Hatano E., Iwaisako K., Osterreicher C. H., Kodama Y., Miura K., Ikai I., Uemoto S., Brenner D. A., Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis Gastroenterology 2008 135 5 1729 1738
42. Xia Y., Chen R., Song Z., Ye S., Sun R., Xue Q., Zhang Z., Gene expression prowles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum Journal of Cancer Research and Clinical Oncology 2010 136 2 309 321